Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 71.50
0.00 (0.00%)
Oct 29, 2025, 3:53 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 27 million as of October 29, 2025. Its market cap has decreased by -3.38% in one year.
Market Cap
27.00M
Enterprise Value
25.28M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
71.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 27.00M, a decrease of -59.70%. That is a compound annual growth rate of -18.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 27.00M | -2.72% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.55B |
| GSK plc | 65.95B |
| Haleon | 30.81B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 3.91B |
| HUTCHMED (China) | 1.90B |
| Genus | 1.68B |